Replies to post #114061 on Innovation Pharmaceuticals Inc (IPIX)

[Ernesto]

Thanks for the thoughts, BK. I agree B-OM is probably the short term mover here.

I believe the orphan designation on K suggests that there had to be some efficacy shown along with the non-toxicity. So any news on K efficacy from Phase 1 isn't really news - we know it did something to earn orphan status.

B Phase 3 along with an uplist was the big driver of the run up earlier this year. The actual B phase 3 news didn't give us much or for very long. I would have never have expected to see the south side of $5 once that news dropped.

We'll see.

[Tails]

A honeycomb of info!
Can't wait till they can list the pII K trials so we can see what we are combined with!

Hang on.... tie yourself in to the saddle. Wild ride ahead!!!

Go CTIX!!